Evidence map›Paper›PMID 30087613›Full record

ArticleFrontiers in pharmacology2018

Ethnobotany of Anti-hypertensive Plants Used in Northern Pakistan.

Khafsa Malik, Mushtaq Ahmad, Rainer W Bussmann, Akash Tariq, Riaz Ullah, Ali S Alqahtani, Abdelaaty A Shahat, Neelam Rashid, Muhammad Zafar, Shazia Sultana and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
9.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 96 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Phytochemical evaluation and anticancer activity of rambutan (Saudi journal of biological sciences · 2021
    Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 5 countries.

Khafsa MalikDepartment of Plant Sciences, Quaid-i-Azam University, Islamabad, Pakistan.
Mushtaq AhmadDepartment of Plant Sciences, Quaid-i-Azam University, Islamabad, Pakistan.
Rainer W BussmannDepartment of Ethnobotany, Institute of Botany, Ilia State University, Tbilisi, Georgia.
Akash TariqKey Laboratory of Mountain Ecological Restoration, Bioresource Utilization and Ecological Restoration Biodiversity Conservation Key Laboratory of Sichuan Province, Chengdu Institute of Biology, Chinese Academy of Sciences, Chengdu, China.
Riaz UllahMedicinal Aromatic and Poisonous Plants Research Center, College of Pharmacy King Saud University, Riyadh, Saudi Arabia.
Ali S AlqahtaniMedicinal Aromatic and Poisonous Plants Research Center, College of Pharmacy King Saud University, Riyadh, Saudi Arabia.
Abdelaaty A ShahatMedicinal Aromatic and Poisonous Plants Research Center, College of Pharmacy King Saud University, Riyadh, Saudi Arabia.
Neelam RashidDepartment of Plant Sciences, Quaid-i-Azam University, Islamabad, Pakistan.
Muhammad ZafarDepartment of Plant Sciences, Quaid-i-Azam University, Islamabad, Pakistan.
Shazia SultanaDepartment of Plant Sciences, Quaid-i-Azam University, Islamabad, Pakistan.
Syed N ShahDepartment of Plant Sciences, Quaid-i-Azam University, Islamabad, Pakistan.
Quaid-i-Azam University · PKKing Saud University · SAChengdu Institute of Biology · CNIlia State University · GENational Research Centre · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hypertension is one of the most important factors responsible for cardiovascular ailments worldwide. It has been observed that herbal products and alternative herbal therapies played a significant role in decreasing hypertension. The aim of the current study is to provide significant ethnopharmacological information, both qualitative and quantitative on medicinal plants related to hypertension from Northern Pakistan. The documented data were quantitatively analyzed for the first time in this area. A total of 250 participants were interviewed through semi-structured discussions and questionnaires. Quantitative indices including FC (Frequency citation), FIV (Family importance value), RFC (Relative frequency of citation) and DCI (Disease Consensus index) were calculated. A total of 192 plant species, belonging to 77 families were reported to be used in treatment of hypertension in Northern Pakistan. The most dominant life form reported was herbs (54%), with decoction (72 reports) and leaves (55.1%) were commonly utilized plant part. Highest FIV was recorded in Lamiaceae (327 FIV). RFC ranged from 0.08 to 1.08% while DCI varied from 0.233 to 0.000. In this study original data was compared with thirty one previous national and international published papers from neighboring region to compare the medicinal uses and obtain some novel plant species. About 42% of the medicinal plant species were reported for the first time in treatment of hypertension in comparison to these 31 published papers. Different phytochemical activities of antihypertensive plants were also reported from literature. This research work documents the traditional knowledge of medicinal plants usage and provides baseline in designing clinical trials and pharmacological analysis for treatment of hypertension.

Indexed as

disease consensus indexethnobotanyhypertensionmedicinal plantNorthern Pakistan

Identifiers

PMID30087613
PMCPMC6066661
OpenAlexW2811187457

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.